THE CHRISTIE PHARMACY LIMITED
Get an alert when THE CHRISTIE PHARMACY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£829K
+10.5% vs 2025
Net assets
£2.5M
+16% highest in 6 filed years
Employees
64
+1.6% highest in 6 filed years
Profit before tax
£460K
+52.3% vs 2025
Net assets
6-year trend · vs Industrials median
Accounts
6-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|---|
| Turnover | £51,168 | £56,267,000 | £65,663,000 | £77,910,000 | £88,662,000 | £100,923,000 | +13.8% | |
| Operating profit | £256 | £576,000 | £477,000 | £503,000 | £323,000 | £428,000 | +32.5% | |
| Profit before tax | £241 | £568,000 | £475,000 | £465,000 | £302,000 | £460,000 | +52.3% | |
| Net profit | — | — | — | £349,000 | £225,000 | £345,000 | +53.3% | |
| Cash | £1,315 | £1,296,000 | £458,000 | £858,000 | £750,000 | £829,000 | +10.5% | |
| Total assets less current liabilities | £1,053 | £1,204,000 | £1,589,000 | £2,094,000 | £2,163,000 | — | — | |
| Net assets | — | £1,204,000 | £1,589,000 | £1,938,000 | £2,163,000 | £2,508,000 | +16% | |
| Equity | £743 | £1,204,000 | £1,589,000 | £1,938,000 | £2,163,000 | £2,508,000 | +16% | |
| Average employees | 43 | 41 | 40 | 53 | 63 | 64 | +1.6% | |
| Wages | — | — | — | £1,861,000 | £2,293,000 | £2,443,000 | +6.5% | |
| Directors' remuneration | — | — | — | £3,000 | £3,000 | £3,000 | 0% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | 0.5% | 1.0% | 0.7% | 0.6% | 0.4% | 0.4% | |
| Net margin | — | — | — | 0.4% | 0.3% | 0.3% | |
| Return on capital employed | 24.3% | 47.8% | 30.0% | 24.0% | 14.9% | — | |
| Gearing (liabilities / total assets) | — | — | — | 75.4% | 73.4% | — | |
| Current ratio | — | — | — | 1.36x | 1.36x | 1.26x | |
| Interest cover | 17.07x | 72.00x | — | 12.57x | 15.38x | 20.38x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having reviewed the company's budget for April 2026 - March 2028, the directors consider that the company has adequate resources to continue in operational existence for the foreseeable future being a period of not less than 12 months from the date of approval of these financial statements and the directors do not believe that there are any material uncertainties which may cast significant doubt on the company to continue as a going concern.”
Significant events
- “The Company last had a General Pharmaceutical Council inspection in January 2025”
- “The last MHRA inspection of the Company in respect of its wholesale medicines dealing activities took place in June 2022.”
- “A Home Office inspection in respect of the Company's Controlled Drugs licence was last undertaken in April 2024. Despite follow-up by the Superintendent Pharmacist, the Home Office inspector has reported that they are still reviewing the licence renewal. In accordance with Home Office advice, the company is continuing to operate in the interim.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHILD, Paul Damian, Mr. | Director | 2022-02-01 | Jun 1965 | British |
| DUDLEY-SOUTHERN, Roy Malcolm | Director | 2024-10-01 | Nov 1946 | British |
| POSTILL, Richard | Director | 2022-10-18 | Apr 1975 | British |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AINSWORTH, Robert David | Director | 2017-10-26 | 2024-09-30 |
| DUNCOMBE, Robert Mark Pigott | Director | 2017-10-23 | 2021-09-01 |
| ELSEY, Rob | Director | 2021-09-01 | 2022-02-01 |
| HACKER, Liesl | Director | 2021-08-02 | 2022-10-18 |
| HACKER, Liesl Ann | Director | 2019-01-31 | 2019-09-05 |
| LARKIN, Joanne | Director | 2019-09-05 | 2020-02-07 |
| PARKINSON, Sally Jane | Director | 2020-03-18 | 2021-08-02 |
| THOMSON, James | Director | 2017-10-23 | 2019-01-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| The Christie Nhs Foundation Trust | Legal person | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-10-23 | Active |
Filing timeline
Last 20 of 37 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-24 | AA | accounts | Accounts with accounts type full | |
| 2025-10-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-25 | AA | accounts | Accounts with accounts type full | |
| 2024-10-16 | AA | accounts | Accounts with accounts type full | |
| 2024-10-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-02 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-15 | AA | accounts | Accounts with accounts type total exemption full | |
| 2023-10-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-27 | AA | accounts | Accounts with accounts type total exemption full | |
| 2022-10-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-18 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-18 | AP01 | officers | Appoint person director company with name date | |
| 2022-02-01 | AP01 | officers | Appoint person director company with name date | |
| 2022-02-01 | TM01 | officers | Termination director company with name termination date | |
| 2021-10-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-01 | TM01 | officers | Termination director company with name termination date | |
| 2021-09-01 | AP01 | officers | Appoint person director company with name date | |
| 2021-08-09 | TM01 | officers | Termination director company with name termination date | |
| 2021-08-09 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.